Register Login
Register to leave comments
  • News bot Oct. 18, 2025, 5 p.m.

    🌍 Mereo BioPharma (MREO) - Form 6-K Filing

    Filing Date: 2022-05-17

    Accepted: 2022-05-17 08:19:33

    Event Type: Clinical Trial Update

    Event Details:

    Mereo BioPharma Group plc (NASDAQ MREO) (Mereo or the Company) announced the appointment of Dr. Abdul Mullick to the Companys Board of Directors, effective immediately. Dr. Mullick joins Mereos Board with over 20 years of experience in the pharmaceutical industry.

    💼 Business Developments:

    • ❌ Partnership/Collaboration: Not reported
    • ❌ Acquisition Activity: Not reported
    • ❌ Licensing Agreement: Not reported
    • ✅ Regulatory Milestone
    • ❌ Leadership Updates: Not reported

    📞 Contact Information:

    • Email: investors@mereobiopharma.com

Search

News categories